Name | UNIFARMA, OOO |
|---|
INN | 7723322154 |
|---|
KPP | 772301001 |
|---|
OGRN | 1027723007410 |
|---|
OKPO | 59147230 |
|---|
Address | 109651, G.MOSKVA, ul. Donetskaya, d. 10, pomesch. 8N |
|---|
Phone | 350-70-47 Contact details |
|---|
Fax | 123-45-61 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 46.46 | Core activity | Wholesale of pharmaceutical goods | | 47.22 | Additional activity | Auto Parts retailer and wholesaler | | 47.73 | Additional activity | Retailing drugs in specialized stores (pharmacies) | | All types of activities | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores |
Registration date | 04.11.2002 |
|---|
Registering department | Inspektsiya Ministerstva Rossiyskoy Federatsii po nalogam i sboram N23 po Yugo-Vostochnomu administrativnomu okrugu g.Moskvy |
|---|
|
UNIFARMA, OOO (Moscow; INN 7723322154) was registered on 4 Nov 2002. The company's authorized capital as of July 1, 2012 was 20000 rub. Type of ownership of UNIFARMA, OOO - Limited liability companies. Form of ownership of UNIFARMA, OOO - Private property. Principal activities of UNIFARMA, OOO: wholesale of pharmaceutical goods (46.46), auto parts retailer and wholesaler (47.22), retailing drugs in specialized stores (pharmacies) (47.73). |
Economic indicators2023
Net profit (RAS) of UNIFARMA, OOO dropped in 2023 by 26.08% to 44.06 million RUB from 59.60 million RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period by 17.34% to 560.40 million RUB from 677.99 million RUB in 2022; cost of goods sold decreased by 16.99% to 524.84 million RUB from 632.23 million RUB; sales loss made up 12.07 million RUB compared to sales profit of 7.13 million RUB. 2022
Net profit (RAS) of UNIFARMA, OOO grew over 2022 1.72 times to 59.60 million RUB from 34.66 million RUB over 2021, the company informed. Revenue increased in the accounting period by 28.29% to 677.99 million RUB from 528.49 million RUB over 2021; cost of goods sold grew by 26.15% to 632.23 million RUB from 501.18 million RUB; sales profit made up 7.13 million RUB compared to sales loss of 11.88 million RUB. 2021
Net profit (RAS) of UNIFARMA, OOO dropped in 2021 by 42.16% to 34.66 million RUB from 59.93 million RUB over the same period in 2020, the company informed. Revenue decreased in the accounting period by 41.63% to 528.49 million RUB from 905.42 million RUB in 2020; cost of goods sold decreased by 42.82% to 501.18 million RUB from 876.49 million RUB; sales loss decreased by 11.54% to 11.88 million RUB from 13.43 million RUB. 2020
Net profit (RAS) of UNIFARMA, OOO grew over 2020 by 9.50% to 59.93 million RUB from 54.73 million RUB over 2019, the company informed. Revenue increased in the accounting period by 25.79% to 905.42 million RUB from 719.78 million RUB over 2019; cost of goods sold grew by 26.12% to 876.49 million RUB from 694.94 million RUB; sales loss decreased by 17.92% to 13.43 million RUB from 16.36 million RUB. 2019
Net profit (RAS) of UNIFARMA, OOO dropped in 2019 by 41.97% to 54.73 million RUB from 94.32 million RUB over the same period in 2018, the company informed. Revenue decreased in the accounting period by 24.66% to 719.78 million RUB from 955.37 million RUB in 2018; cost of goods sold decreased by 24.87% to 694.94 million RUB from 924.96 million RUB; sales loss grew 1.53 times to 16.36 million RUB from 10.67 million RUB. 2018
Net profit (RAS) of UNIFARMA, OOO dropped in 2018 by 19.57% to 94.32 million RUB from 117.27 million RUB over the same period in 2017, the company informed. Revenue increased in the accounting period by 6.55% to 955.37 million RUB from 896.64 million RUB over 2017; cost of goods sold grew by 7.47% to 924.96 million RUB from 860.70 million RUB; sales loss grew 2.18 times to 10.67 million RUB from 4.90 million RUB. 2017
Net profit (RAS) of UNIFARMA, OOO grew over 2017 by 28.25% to 117.27 million RUB from 91.44 million RUB over 2016, the company informed. Revenue increased in the accounting period by 14.50% to 896.64 million RUB from 783.10 million RUB over 2016; cost of goods sold grew by 15.21% to 860.70 million RUB from 747.08 million RUB; sales loss decreased by 49.02% to 4.90 million RUB from 9.62 million RUB. 2016
Net profit (RAS) of UNIFARMA, OOO dropped in 2016 by 10.20% to 91.44 million RUB from 101.82 million RUB over the same period in 2015, the company informed. Revenue decreased in the accounting period by 14.30% to 783.10 million RUB from 913.77 million RUB in 2015; cost of goods sold decreased by 14.31% to 747.08 million RUB from 871.83 million RUB; sales loss grew 39.41 times to 9.62 million RUB from 244.00 thousand RUB. 2014
Net profit (RAS) of Unifarma, OOO grew over 2014 by 22.65% to 72.15 million RUB from 58.83 million RUB over 2013, the company informed. Revenue increased in the accounting period by 3.95% to 774.52 million RUB from 745.11 million RUB over 2013; cost of goods sold grew by 3.39% to 736.71 million RUB from 712.57 million RUB; sales profit made up 992.00 thousand RUB compared to sales loss of 1.74 million RUB. 2013
Net profit (RAS) of Unifarma, OOO grew over 2013 2.93 times to 58.83 million RUB from 20.07 million RUB over 2012, the company informed. Revenue decreased in the accounting period by 5.29% to 745.11 million RUB from 786.76 million RUB in 2012; cost of goods sold decreased by 7.48% to 712.57 million RUB from 770.14 million RUB; sales loss decreased 4.07 times to 1.74 million RUB from 7.09 million RUB. 2012
Net profit (RAS) of UNIFARMA, OOO grew over 2012 3.73 times to 20.07 million RUB from 5.38 million RUB over 2011, the company informed. Revenue increased in the accounting period by 39.36% to 786.76 million RUB from 564.56 million RUB over 2011; cost of goods sold grew by 37.59% to 793.85 million RUB from 576.98 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|